Osteoarthritis (OA) is a chronic degenerative joint disorder characterized by destruction of the articular cartilage, subchondral bone alterations and synovitis. Matrix metalloproteinases (MMPs) are expressed in joint tissues of patients with osteoarthritis (OA). The objective of this study was to define the steady state levels of two different MMPs to provide more insight into the role of MMPs in cartilage destruction in OA. We investigated the expression of gelatinases through immunohistochemistry Our results show that high levels of MMP-2 and MMP-9 are present in OA and suggest that once these MMPs are fully activated they may contribute to the cartilage destruction in OA.
Osteoarthritis is one of the most common diseases worldwide, affecting more than 100 million individuals. Risk factors (age, occupation and gender) of OA are closely related to the mechanical loading of the joints and it is assumed that a large part of OA is induced by accumulated mechanical stress (I). The major problem in the treatment of OA is that articular cartilage (Ae) has poor potential healing, related to the low regenerative capacity of articular chondrocytes. The pathology of disease process leads to destruction of the articular cartilage by release of deleterious proteinases from articular chondrocytes, inducing excessive degradation of cartilage extracellular matrix (ECM). Articular cartilage has a simple avascular structure composed of a large amount of ECM and a small number of chondrocytes and is the major target tissue for destruction in osteoarthritis (2) .
Over a long period, our group has been studying the expression of metalloproteinases (MMP-2; MMP-9) in healthy and pathological samples (human oral mucosa and salivary gland tumors) by immunohistochemistry and RT-PCR to investigate the entity of the remodelling processes (3) (4) (5) . The objective of this study is to define the steady levels of two different MMPs to provide more insight into the role of MMPs in cartilage destruction in OA.
MATERIALS AND METHODS

Samples
Twenty articular cartilage specimens were obtained from patients with osteoarthritis (OA) who underwent total knee or hip arthroplasty. OA was diagnosed by clinical and radiological evaluation based on the American College of Rheumatology criteria. Patients who presented with evident joint injury or generalised OA were excluded from the study. Patients were not treated with intraarticular injections of steroid, chondroitin polysulphate or hyaluronic acid for at least one month prior to this study.
Control specimens were collected from 10 patients with no history of joint disease who underwent joint surgery after femoral neck fracture. All samples were obtained after informed consent from the patients. The experiments were carried out in accordance with the Declaration of Helsinki.
Immunohistochemistry
Tissue specimens were fixed in 4% buffered formalin. After fixation the tissue was dehydrated in a graded series of alcohols, cleared in xylene and paraffin embedded. Section 7 urn were obtained with a microtome ( Leica RM2145), stored overnight at 3T'C and then stored at room temperature until use. On the day of the experiment, slides were dewaxed in xylene and rehydrated in a graded series of alcohols. Slides were then transferred into distilled water for 5 min. Immunohistochemistry was performed using the Dako Cytomation EnVision+ System-HRP (AEC) kit (Dako, Glostrup Denmark) following the manufacturer's instructions. Briefly, sections were covered with the peroxidase block reagent and incubated 5 min at room temperature. The samples were rinsed once in PBS buffer pH7.2 and the sections were covered with antibody solution and incubated in a humid chamber overnight at 4°C. Mouse anti-human MMP-2 monoclonal antibody (MAB3308, Chemicon Millipore, MA, USA) at I:800 dilution and rabbit polyclonal antimouse full length MMP-9 antibody (ABI9047, Chemicon Mi1Iipore, MA, USA) at I: 100 dilution were used. The antibodies were diluted in 0.1% BSA in PBS. The sections were washed twice in PBS pH 7.2, incubated with Peroxidase Labelled Polymer reagent, washed twice in PBS pH 7.2, incubated with the Substrate-Chromogen 2 reagent and immediately placed under a light microscope. The reaction was visually monitored and stopped by distilled water as the staining appeared (2-10 min). Negative controls were obtained by the same immunostaining in which the primary antibody was omitted. The sections were coverslipped using Dako Cytomation Faramount Aqueous Mounting Medium, then were observed under a Leica DM 1000 microscope.
Semi-quantitative evaluation ofImmunoreactivity
The intensity of immunostaining for MMP-2 and MMP-9 in specimens was evaluated by three independent observers according to the following criteria: (0) no staining, (I) weak staining, (2) moderate staining, (3) strong staining, (4) very strong staining.
RESULTS
The immnunodistributions of MMP-2 and MMP-9 were examined in specimens of OA and normal cartilage. The specimens provided examples that were representative of OA grades 1,2,3 for comparison with age-matched normal articular cartilage, graded as O. Immunolocalization of the two gelatinases (MMP-2 and MMP-9) was limited to small groups of chondrocytes with rather strong staining ( Fig. 1 ). Control tissue sections from OA grade 3 cartilage gave immunonegative results.
Immunostaining for MMP-2 and MMP-9 was most prominent in the superficial zone of OA grades 2 and 3, especially associated with areas of extracellular matrix depletion, fibrillations, chondrocytes, clusters and loss of metachromasia. By contrast, the MMP immunostaining was reduced or absent within the deep zone of these specimens. From a few cell clusters, this deep zone showed apparently normal hyaline cartilage and chondrocyte morphology (Figs. 2, 3, 4 ). All the OA specimens showed a greater frequency and distribution of each MMP compared with normal articular cartilage specimens.
DISCUSSION
Cartilage ECM is composed mainly of proteoglycans including the major proteoglycan, aggrecans, and other minor proteoglycans and collagens such as fibrillar type II collagen and other minor collagens (type IX, XI and VI). Depletion of proteoglicans occurs early and the degradation of fibrils follows.
After the initiation of collagen fibrillation, laceration of the articular cartilage begins and is a result of the destruction of the cascade structures of the collagen fibrils in the articular cartilage, which is composed of superficial, transitional, radial and calcified zones.
Destruction ofcartilage is a common pathological feature in various joint diseases, and is a major cause of joint dysfunction, which is followed by impairment of the quality of life in those patients. Two pathways are known for the destruction of the cartilage: the former, an intrinsic pathway in which chondrocytes degrade cartilage extracellular matrix (ECM); the latter, an extrinsic pathway in which tissues or cells other than chondrocytes, such as inflamed synovium, pannus tissue, and infiltrated inflammatory cells, cause the extracellular matrix (ECM) breakdown, mostly through synovial fluid. In both pathways, enzyme digestion of ECM is responsible for cartilage destruction (6) . angiogenesis, apoptosis and immunodefence. MMPs are distinguished from other endopeptidases by their dependence on metal ions as cofactors, their ability to degrade extracellular matrix and their specific evolutionary DNA sequence. They are grouped based partly on historical assessment of substrate specificity and partly on cellular localization: collagenases, gelatinases, stromelysins and membrane-type MMPs. The main substrates of gelatinases (MMP-2; MMP-9) are type IV collagen; these enzymes are distinguished by the presence ofan additional domain inserted into the catalytic domain and by the presence of cartilage matrix degradation in localized sites (7) (8) (9) .
It is known that MMP-2 is produced by stromal cells in the sublining synovial layer while MMP-9 is secreted by neutrophils, macrophages and synovial cells. In addition, the expression of these MMPs in chondrocytes has also been reported in literature data. In this study, we determined the levels ofMMP-2 and MMP-9 in articular cartilage specimens from patients with OA. MMP-2 and MMP-9 are localized solely in the calcified cartilage and the subchondral bone area.
Studies have shown that, among the seven different MMPs (MMP-l, MMP-2, MMP-3, MMP-7, MMP-8, MMP-9 and MMP-13), the levels of both MMP-2 and MMP-9 are significantly enhanced in patients with OA compared with controls (10) . Cartilage degradation and loss are the major features of OA; degenerative changes include fibrillations, chondrocyte proliferation into cell clusters, and matrix disruption. Recent studies have implicated the up-regulation of several matrix-degrading metalloproteinases in OA cartilage. Several reports have proposed that chondrocyte production of MMPs in OA cartilage reflects a local synthesis which is corresponding to the extent of cartilage degeneration. However, the mechanisms which regulate MMP expression, the relative importance of individual MMPs, and their distributions in situ remain uncertain (11-13). The major aim of the present study is to examine the MMP expression of chondrocytes in human OA cartilage specimens and to determine whether these are related to the progressive degenerative changes of OA.
Numerous immunohistochemical studies show the presence of MMPs in OA cartilage of various animal species and humans, many of which have identified MMP distribution in tissue but the results are controversial. One explanation for disagreement may be related to differences in the relatively shortterm experimental OA animals models compared with the different cartilage location, joint feature and clinical grading of human OA specimens (14) (15) (16) . Other studies used isolated chondrocyte colture or cartilage explants to examine the expression of MMPs mRNA and/or protein in normal and OAderived chondrocytes (17) (18) (19) (20) (21) .
In the present study, the MMP expression of OA chondrocytes showed variations within specimens of the same grade. Only occasionally was the extent of immunostaining in the deep zone similar to that of the superficial zone. Thus, the results did not always conform to the expected pattern. In general, we showed that both MMPs are were more intensely expressed by chondrocytes of the superficial zone, where degenerative changes were more prominent. These findings are largely consistent with the data reported by others Authors (22) , who reported the immune reaction and direct correlation for some MMPs of the superficial zones of OA cartilage with more advanced cartilage degradation. The knowledge that OA cartilage specimens show microenvironmental variations in MMPs expression despite similar histologic grading probably reflects the intermittent nature ofactive and quiescent phases of disease progression in OA.
In conclusion, the present findings further confirm the previous studies on chondrocytes and cartilage explants or on human OA cartilage samples which have emphasized the importance of MMPs in the beginning and progress of cartilage degeneration (23, 24) .
